Expression pattern of telomerase reverse transcriptase in rectal carcinoma predicts tumor radiosensitivity, local recurrence and disease-free survival

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 985-989

  Komuro, Yasuhiro ^a   Watanabe, Toshiaki ^a   Tsurita, Giichiro ^a   Muto, Tetsuichiro ^b   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Immunohistochemistry; Preoperative radiotherapy; Rectal carcinoma; Telomerase reverse transcriptase

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; RECTUM CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RADIATION TOLERANCE; RECTAL NEOPLASMS; TELOMERASE; TREATMENT OUTCOME;

EID: 21744442895     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 1997; 336:980-987.
2. Dahlberg M, Glimelius B, Pahlman L: Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg 1999; 229:493-497.
3. Sause WT, Pajak TF, Noyes RD, Dobelbower R, Fischbach J, Doggett S, Mohiuddin M: Evaluation of preoperative radiation therapy in operable colorectal cancer. Ann Surg 1994; 220:668-675.
4. Holm T, Cedermark B, Rutqvist LE: Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br J Surg 1994; 81:452-405.
5. Marsh PJ, James RD, Schofield PF: Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial. Dis Colon Rectum 1994; 37:1205-1214.
6. Komuro Y, Watanabe T, Hosoi Y, Matsumoto Y, Nakagawa K, Tsuno N, Kazama S, Kitayama J, Suzuki N, Nagawa H: The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer 2002; 95:1199-1205.
7. Blackburn EH: Structure and function of telomeres. Nature 1991; 350:569-573.
8. Run NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-2015.
9. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J: The RNA component of human telomerase. Science 1995; 269:1236-1241.
10. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277:955-959.
11. Nakamura TM, Cooper JP, Cech TR: Two modes of survival of fission yeast without telomerase. Science 1998; 282:493-496.
12. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddie SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90:785-795.
13. Lee KH, Rudolph KL, Ju YJ, Greenberg RA, Cannizzaro L, Chin L, Weiler SR, DePinho RA: Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci USA 2001; 98:3381-3386.
14. Ludwig A, Saretzki G, Holm PS, Tiemann F, Lorenz M, Emrich T, Harley CB, von Zglinicki T: Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res 2001; 61:3053-3061.
15. Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA: Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 2000; 192:1625-1636.
16. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C, Artandi SE, Rudolph KL, Gottlieb GJ, Chin L, Alt FW, DePinho RA: Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 2000; 26:85-88.
17. Greider CW: Telomere length regulation. Annu Rev Biochem 1996; 65:337-365.
18. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11:1921-1929.
19. Wei R, Younes M: Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa. Hum Pathol 2002; 33:693-696.
20. Kumaki F, Kawai T, Hiroi S, Shinomiya N, Ozeki Y, Ferrans VJ, Torikata C: Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum Pathol 2001; 32:188-195.
21. Gertler R, Rosenberg R, Stricker D, Werner M, Lassmann S, Ulm K, Nekarda H, Siewert JR: Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma. Cancer 2002; 95:2103-2111.
22. Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T: High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res 2000; 6:2696-2701.
23. Sato N, Mizumoto K, Nagai E, Tanaka M: Telomerase as a new target for pancreatic cancer treatment. J Hepatobiliary Pancreat Surg 2002; 9:322-327.
24. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW: Telomerase activity in human brain tumours. Lancet 1995; 346:1267-1268.
25. Hiyama K, Hirai Y, Kyolzumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155:3711-3715.
26. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, Harley CB: Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995; 220:194-200.
27. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW, Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 1995; 55:3258-3262.
28. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA, Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87:895-902.
29. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1:249-255.
30. Lee JC, Jong HS, Yoo CG, Han SK, Shim YS, Kim YW: Telomerase activity in lung cancer cell lines and tissues. Lung Cancer 1998; 21:99-103.
31. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y: Telomerase activity in human bladder cancer. Clin Cancer Res 1996; 2:929-932.
32. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y: Telomerase activity in primary prostate cancer. J Urol 1997; 157:1161-1165.
33. Miyoshi Y, Tsukinoki K, Imaizumi T, Yamada Y, Ishizaki T, Watanabe Y, Sasakura Y, Lin Y, Hosaka M, Kubota Y: Telomerase activity in oral cancer. Oral Oncol 1999; 35:283-289.
34. Rha SY, Park KH, Kim TS, Yoo NC, Yang WI, Roh JK, Min JS, Lee KS, Kim BS, Choi JH, Lim HY, Chung HC: Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast. Int J Oncol 1999; 15:839-845.
35. James RD, Haboubi N, Schofield PF, Mellor M, Salhab N: Prognostic factors in colorectal carcinoma treated by preoperative radiotherapy and immediate surgery. Dis Colon Rectum 1991; 34:546-551.